Showing 1 - 5 results of 5 for search 'Peng-Yu Zhang', query time: 0.04s Refine Results
  1. 1
    Characteristics of fires in coal mine roadways and comparative analysis of control effectiveness between longitudinal ventilation and cross-section sealing

    Characteristics of fires in coal mine roadways and comparative analysis of control effectiveness between longitudinal ventilation and cross-section sealing by Li Ma, Jing Fan, Rui-Zhi Guo, Peng-Yu Zhang, Chao-Hua Li

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Early Fever Is Associated With Clinical Outcomes in Patients With Coronavirus Disease

    Early Fever Is Associated With Clinical Outcomes in Patients With Coronavirus Disease by Feng-ming Ding, Yun Feng, Lei Han, Yan Zhou, Yong Ji, Hui-juan Hao, Yi-shu Xue, Dong-ning Yin, Zeng-chao Xu, Shan Luo, Peng-yu Zhang, Peng-yu Zhang, Min Zhang

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

    Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor... by Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Ju Bai, Yan Xu, Xu-Geng Wang, Rui-Li Zhang, Li-Li Wei, Qiu-Chuan Zhuang, Frank Fan, Wang-Gang Zhang, Ai-Li He, Jie Liu

    Published 2022-12-01
    Get full text
    Article
  4. 4
    A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

    A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple my... by Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Nan Yang, Ru Zhang, Hui Zhang, Ying Shen, Ju Bai, Yan Xu, Xu-Geng Wang, Rui-Li Zhang, Li-Li Wei, Zong-Fang Li, Zhen-Zhen Li, Yan Geng, Qian He, Qiu-Chuan Zhuang, Xiao-Hu Fan, Ai-Li He, Wang-Gang Zhang

    Published 2018-12-01
    Get full text
    Article
  5. 5
    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2) by Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, Wei-Jun Fu, Jie Xu, Jie Liu, Shi-Wei Jin, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Hui Zhang, Ju Bai, Yan Xu, Han Zhu, Juan Du, Hua Jiang, Xiao-Hu Fan, Jian-Yong Li, Jian Hou, Zhu Chen, Wang-Gang Zhang, Jian-Qing Mi, Sai-Juan Chen, Ai-Li He

    Published 2022-07-01
    Get full text
    Article

Search Tools: